Krystal Biotech Inc (NAS:KRYS)
$ 155.42 -3.58 (-2.25%) Market Cap: 4.44 Bil Enterprise Value: 4.04 Bil PE Ratio: 82.67 PB Ratio: 5.55 GF Score: 38/100

Krystal Biotech Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 08:55PM GMT
Release Date Price: $127.34 (-0.86%)
Albert Wang

Good afternoon, everybody. Thank you for coming to the Morgan Stanley Healthcare Conference. My name is Albert Wang. I am on the investment banking side, I'm a Managing Director, and I co-head the U.S. health care business.

I'm going to read a quick disclosure here. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley representative.

Okay. Great. So Krish, maybe you can introduce yourself quickly before we get started.

Krish S. Krishnan
Krystal Biotech, Inc. - Founder, Chairman, President & CEO

Yes. Krish Krishnan, Chairman and CEO of Krystal Biotech. Thanks for having us here, Albert.

Questions & Answers

Albert Wang

Okay. Great. So maybe we'll start out at a very high level, for the uninitiated, if you can give a couple of sentences on Krystal and some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot